Intco Medical Hits Day High with 5.49% Surge, Outperforming Market

Intco Medical Technology Co., Ltd. has experienced a significant uptick in its stock performance, gaining 5.49% on March 17, 2026. The stock reached an intraday high of CNY 63.50, showcasing its strong market position within the Pharmaceuticals & Biotechnology sector. Over the past year, Intco Medical has demonstrated impressive growth, with a remarkable 149.19% increase in stock value, significantly outperforming the China Shanghai Composite, which rose only 18.21% during the same period. The company's performance metrics reflect a robust operational framework, highlighted by a record operating cash flow of CNY 2,119.78 million and a return on capital employed (ROCE) of 9.77%. Additionally, Intco Medical has maintained a favorable price-to-book ratio of 1.37 and a solid return on equity (ROE) of 6.76%. The company has also reported a decrease in raw material costs by 10.74% year-over-year, contributing to its positive financial trajectory. With a market capitalization of CNY 18,343 million, Intco Medical continues to solidify its position as a leading player in its industry.